BHVN
Price
$29.41
Change
-$0.00 (-0.00%)
Updated
Mar 12, 04:59 PM (EDT)
Capitalization
3B
58 days until earnings call
KRYS
Price
$179.84
Change
-$5.04 (-2.73%)
Updated
Mar 12, 03:00 PM (EDT)
Capitalization
5.33B
61 days until earnings call
Ad is loading...

BHVN vs KRYS

Header iconBHVN vs KRYS Comparison
Open Charts BHVN vs KRYSBanner chart's image
Biohaven
Price$29.41
Change-$0.00 (-0.00%)
Volume$6.18K
Capitalization3B
Krystal Biotech
Price$179.84
Change-$5.04 (-2.73%)
Volume$200
Capitalization5.33B
BHVN vs KRYS Comparison Chart
Loading...
BHVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KRYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BHVN vs. KRYS commentary
Mar 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BHVN is a Hold and KRYS is a Buy.

Ad is loading...
COMPARISON
Comparison
Mar 12, 2025
Stock price -- (BHVN: $29.41 vs. KRYS: $184.88)
Brand notoriety: BHVN and KRYS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BHVN: 194% vs. KRYS: 126%
Market capitalization -- BHVN: $3B vs. KRYS: $5.33B
BHVN [@Biotechnology] is valued at $3B. KRYS’s [@Biotechnology] market capitalization is $5.33B. The market cap for tickers in the [@Biotechnology] industry ranges from $355.07B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BHVN’s FA Score shows that 0 FA rating(s) are green whileKRYS’s FA Score has 1 green FA rating(s).

  • BHVN’s FA Score: 0 green, 5 red.
  • KRYS’s FA Score: 1 green, 4 red.
According to our system of comparison, KRYS is a better buy in the long-term than BHVN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BHVN’s TA Score shows that 5 TA indicator(s) are bullish while KRYS’s TA Score has 6 bullish TA indicator(s).

  • BHVN’s TA Score: 5 bullish, 5 bearish.
  • KRYS’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, KRYS is a better buy in the short-term than BHVN.

Price Growth

BHVN (@Biotechnology) experienced а -6.25% price change this week, while KRYS (@Biotechnology) price change was +5.51% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.72%. For the same industry, the average monthly price growth was -6.30%, and the average quarterly price growth was -7.81%.

Reported Earning Dates

BHVN is expected to report earnings on May 09, 2025.

KRYS is expected to report earnings on May 12, 2025.

Industries' Descriptions

@Biotechnology (-0.72% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KRYS($5.33B) has a higher market cap than BHVN($3B). KRYS YTD gains are higher at: 18.014 vs. BHVN (-21.258). KRYS has higher annual earnings (EBITDA): 110M vs. BHVN (-841.6M). KRYS has more cash in the bank: 598M vs. BHVN (379M). KRYS has less debt than BHVN: KRYS (7.26M) vs BHVN (29M). KRYS has higher revenues than BHVN: KRYS (291M) vs BHVN (0).
BHVNKRYSBHVN / KRYS
Capitalization3B5.33B56%
EBITDA-841.6M110M-765%
Gain YTD-21.25818.014-118%
P/E RatioN/A61.63-
Revenue0291M-
Total Cash379M598M63%
Total Debt29M7.26M399%
FUNDAMENTALS RATINGS
BHVN vs KRYS: Fundamental Ratings
BHVN
KRYS
OUTLOOK RATING
1..100
5917
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
80
Overvalued
PROFIT vs RISK RATING
1..100
10016
SMR RATING
1..100
10067
PRICE GROWTH RATING
1..100
9145
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BHVN's Valuation (64) in the Pharmaceuticals Major industry is in the same range as KRYS (80). This means that BHVN’s stock grew similarly to KRYS’s over the last 12 months.

KRYS's Profit vs Risk Rating (16) in the Pharmaceuticals Major industry is significantly better than the same rating for BHVN (100). This means that KRYS’s stock grew significantly faster than BHVN’s over the last 12 months.

KRYS's SMR Rating (67) in the Pharmaceuticals Major industry is somewhat better than the same rating for BHVN (100). This means that KRYS’s stock grew somewhat faster than BHVN’s over the last 12 months.

KRYS's Price Growth Rating (45) in the Pharmaceuticals Major industry is somewhat better than the same rating for BHVN (91). This means that KRYS’s stock grew somewhat faster than BHVN’s over the last 12 months.

KRYS's P/E Growth Rating (100) in the Pharmaceuticals Major industry is in the same range as BHVN (100). This means that KRYS’s stock grew similarly to BHVN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BHVNKRYS
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
72%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
72%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bearish Trend 2 days ago
70%
Bullish Trend 2 days ago
72%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
74%
Bullish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 15 days ago
75%
Bullish Trend 2 days ago
76%
Declines
ODDS (%)
Bearish Trend 3 days ago
73%
Bearish Trend 14 days ago
76%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
81%
View a ticker or compare two or three
Ad is loading...
BHVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KRYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X82862.2100004330.211000
+5.51%
Bitcoin cryptocurrency
TSLA230.588.43
+3.79%
Tesla
GME22.610.19
+0.85%
GameStop Corp
SPY555.92-4.66
-0.83%
SPDR® S&P 500® ETF Trust
AAPL220.84-6.64
-2.92%
Apple

BHVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, BHVN has been loosely correlated with OCUL. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if BHVN jumps, then OCUL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BHVN
1D Price
Change %
BHVN100%
+6.44%
OCUL - BHVN
42%
Loosely correlated
+11.24%
KRYS - BHVN
39%
Loosely correlated
+0.61%
ABSI - BHVN
39%
Loosely correlated
-3.59%
APGE - BHVN
37%
Loosely correlated
+7.27%
ACLX - BHVN
37%
Loosely correlated
-5.21%
More

KRYS and

Correlation & Price change

A.I.dvisor indicates that over the last year, KRYS has been loosely correlated with ACLX. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if KRYS jumps, then ACLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KRYS
1D Price
Change %
KRYS100%
+0.61%
ACLX - KRYS
50%
Loosely correlated
-5.21%
BEAM - KRYS
47%
Loosely correlated
+2.82%
PRME - KRYS
46%
Loosely correlated
-8.65%
PRTA - KRYS
46%
Loosely correlated
-5.79%
RGNX - KRYS
45%
Loosely correlated
+1.66%
More